GAO Finds Medical Care Failures in 45% of Federal Prison Deaths
The Federal Bureau of Prisons (BOP) identified deficiencies in medical care in 45% of natural deaths in federal custody during fiscal 2024, with some of...
Data and News Shaping the Political Landscape
The Federal Bureau of Prisons (BOP) identified deficiencies in medical care in 45% of natural deaths in federal custody during fiscal 2024, with some of...
Medicare Part D plans generally did not cover over-the-counter naloxone nasal sprays in 2025, while Medicaid covered them in 2024, according to a Government...
Whidbey Health (Coupeville, Wash.) has signed Johnston Group to lobby for it, according to a new client registration signed Nov. 6. The lobbying...
Point32Health Inc. is lobbying on Medicare as the Centers for Medicare & Medicaid Services (CMS) said Sept. 28 that Medicare Advantage and Part D programs...
Medicare home health agencies face new payment rates and reporting requirements for 2027, changing how they are paid and what they must report, under a...
Medicare prescription drug plans, manufacturers whose drugs are selected for price negotiations and Medicare beneficiaries face new requirements as the...
Hospitals and surgery centers paid by Medicare for outpatient care will receive revised 2027 payment rates, and patients receiving certain botulinum toxin...
Doctors who bill Medicare will be paid at lower conversion factors, and drugmakers and noncitizen patients face new requirements after Health and Human...
The Food and Drug Administration (FDA) released a new draft chapter of its preventive controls guidance for human food covering chemical hazards, including...
The Department of Health and Human Services is removing 14 of the 60 health information technology certification criteria under its voluntary certification...
The Department of Health and Human Services is changing Medicare and Medicaid rules governing all 54 organ procurement organizations, allowing service areas...
The Drug Enforcement Administration placed centanafadine, the newly FDA-approved ADHD drug sold as Simtriyo, in Schedule III of the Controlled Substances...
The Labor Department finalized a rule requiring pharmacy benefit management firms and their affiliated brokers and consultants to disclose their...
Infant formula makers would face new nutrient floors and ceilings and mandatory relabeling under a Food and Drug Administration proposal published November...
Health insurance Marketplace applicants and enrollees would face new eligibility and verification checks before coverage begins, under a proposal the...
The Food and Drug Administration (FDA) published draft guidance limiting cadmium, a toxic transition metal, in processed foods for babies and young children...
The Department of Health and Human Services (HHS) proposed eliminating generic-drug copays for about 6 million low-income Medicare enrollees and barring...
Private health insurance market concentration generally increased from 2011 through 2024, leaving enrollees with potentially fewer insurer choices and...
Smith & Nephew Inc. is lobbying on the Medicare physician fee schedule and hospital outpatient payment rules governing skin substitutes, wound-care products...
The Trump administration terminated the Medicare Part D Premium Stabilization Demonstration in 2026, cutting short a program designed to run through plan...